Clinical trial
A Multi-centre, Double-blind Randomised Controlled Trial to Compare Mirtazapine Versus Placebo Over 12 Weeks in Patients With Multimorbid Major Depression and Inflammatory Bowel Disease (MD-IBD): a Feasibility Study
NCT06309472 is registered in ClinicalTrials.gov with King's College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-centre, Double-blind Randomised Controlled Trial to Compare Mirtazapine Versus Placebo Over 12 Weeks in Patients With Multimorbid Major Depression and Inflammatory Bowel Disease (MD-IBD): a Feasibility Study
- Lead sponsor
- King's College London
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 7, 2024
- Completion date
- November 3, 2025
- Enrollment
- 76 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.